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Background. In the ﬁeld of cancer, best practice is given by a compendium of clinical guidelines in text form. However, there are
concerns over lack of an appropriate platform for decision-making.
Aim. The objective of this study is to design and create an advanced clinical decision support system (CDSS) based upon different
artiﬁcial intelligence techniques such as data mining and the use of Bayesian classify trees to assist in the therapeutic process
of breast cancer.
Methods. First, all patient data was properly codiﬁed, according to certain standard taxonomies, in order to be computed in the
inference engine of a CDSS. Patient descriptors were identiﬁed by seven expert physicians in breast cancer including radiation
oncologists (N=5), pathologists (N=2), a medical oncologist, a surgeon, and a radiologist. Second, using international (National
Comprehensive Cancer Network) and regional (Proceso Asistencial Integrado de Cancer de Mama) clinical guidelines, we applied
machine learning algorithms to ﬁnd predictive models and also streaming mining to biomedical data.
Results. The ﬁrst step (patient descriptors identiﬁcation) took approximately three months for completion. A total of 442 patient
descriptorswere identiﬁed by the seven expert physicians in breast cancer. Secondly, the toolwas able to provide the user relevant
information in real time such as the TNM classiﬁcation for breast cancer or the Karnofsky index deﬁnition. In addition, the tool
provided prompts and reminders when needed (i.e. the possibility of allergies or pregnancy before treatment). Finally, the CDSS
generated an automatic suggestion for an evidence-based management.
Conclusions. AnadvancedCDSS is able to evaluate all available breast cancer patient data in real timeandoffer prompts, reminders,
and suggestions for an evidence-based management. In addition, the CDSS reduces the variability among physicians and may
also help patients to make important decisions about treatment.
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